Articles les plus consultés

  • Les futures sur cac belle glissade < vix pas bon + 3%
        francis 13 Version sans publicité Marchés   Actualités   Analyses   Crypto   Fonds   Graphiques   Technique   Brokers   Outils   Portefe...
  • Nouvelles applications de médicaments avec des documents de soutien
    6% Hydroxyethyl Starch 130 / 0.4 in 0.9% Injection de chlorure de sodium (Voluven 500 mL freeflex flexible en plastique intraveineuse solut...
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Iridium   14.95 + 39.07% 0,60K Mondialisation de l'Inde.   0,4800 + 18,52% 1,80K...
  • pre-market
    Top Gaining Stocks % Chg Dernier Symb Compagnie Le volume 16,22% 2.15 SRNE Sorrento Therapeut 7030 10,92% 2,64 CIE Cobalt Inte...
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Oracle Corporation   51.30 + 10,73% 58.90K Staples Inc   9.25 + 6,81% 12,31K Delcat...
  • pre_market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Delcath   0.1230 + 24,24% 196,67K Neos Therapeutics I.   10.50 +16.67% 34.36K Enpha...
  • les élus
    Citoyens_Français ‏   @citoyenneFrance     8 juin Plus Attali : « Les élus n’ont plus de pouvoir et voici votre avenir » - Effr......
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Lipocine In   5.32 + 32,34% 38.64K Enphase Energy Inc   0,938 + 17,57% 10,37K Delca...
  • bonjour.. approbations
    28 juin 2017 Nom du médicament et  numéro de demande Ingrédient actif Formulaire de posologie / itinéraire Soumission Compagnie ...
  • $ pré-market
    Plus fortes hausses en préouverture Nom Dernier Var.% Vol. DragonWave Inc   1,3900 +25,23% 3,55K Alibaba   139,95 +11,35% 1,40M MoSys...

jeudi 5 avril 2018

Virbac : Declaration of the number of shares and voting rights as of March 2018, 31.

Virbac : Declaration of the number of shares and voting rights as of March 2018, 31.
Posted by at Aucun commentaire:

Investorideas.com - CSE Top Percentage Gainers April 4th; (CSE: $FNQ.C), (CSE: $JBR.C), (CSE: $MAY.C), (CSE: $BBT.C) ;@CSE_News

Investorideas.com - CSE Top Percentage Gainers April 4th; (CSE: $FNQ.C), (CSE: $JBR.C), (CSE: $MAY.C), (CSE: $BBT.C) ;@CSE_News
Posted by at Aucun commentaire:

Magenta Therapeutics Announces First Patient Transplanted with MGTA-456 in Phase 2 Study in Inherited Metabolic Disorders | Business Wire

Magenta Therapeutics Announces First Patient Transplanted with MGTA-456 in Phase 2 Study in Inherited Metabolic Disorders | Business Wire: Magenta Therapeutics, a biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients, today
Posted by at Aucun commentaire:

PACIRA

Pacira Pharmaceuticals Inc
NASDAQ: PCRX
Suivre

28,85 USD +0,85 (3,04%)
Fermé: 5 avril, 8h00 HAE · Avertissement
Pré-marché 30.00+1.15 (3.99%)  


Posted by at Aucun commentaire:

Aradigm Announces the EMA Has Completed Its Validation of the MAA Submission | Business Wire

Aradigm Announces the EMA Has Completed Its Validation of the MAA Submission | Business Wire: Aradigm Corporation (NASDAQ: ARDM) (the
Posted by at Aucun commentaire:

Theratechnologies annonce ses résultats financiers du premier trimestre de 2018

Theratechnologies annonce ses résultats financiers du premier trimestre de 2018
Posted by at Aucun commentaire:

Evolus Phase III European - Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to Botox® Meets Primary Endpoint

Evolus Phase III European - Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to Botox® Meets Primary Endpoint: Results presented today at 2018 Aesthetic and Anti-Aging Medicine World Congress (AMWC)
Posted by at Aucun commentaire:
Inscription à : Articles (Atom)